INTRODUCTION
============

Minimising total ischemic time (TIT) is important for improving the clinical outcome of patients with ST-segment elevation myocardial infarction (STEMI) \[[@b1-kjim-2019-123]\]. Over recent decades, timely reperfusion of the culprit vessel has been a major goal of STEMI treatment. Prompt treatment is required for myocardial salvage because of the time-dependent nature of reperfusion therapies such as primary percutaneous coronary intervention (PPCI) \[[@b2-kjim-2019-123],[@b3-kjim-2019-123]\]. Despite the improved door-to-balloon times (DTBTs), no reduction in total ischemic time has been observed \[[@b4-kjim-2019-123]\]. One of the barriers to reducing ischemic time is a pre-hospital (or patient-related) delay, which is usually expressed as symptom-to-door time (STDT) \[[@b5-kjim-2019-123]\].

STDT could be one of the most important factors in reducing TIT in STEMI patients undergoing PPCI. In terms of the healthcare system, regional well-organised emergency medical services (EMS) would be helpful for reducing the time to reperfusion \[[@b6-kjim-2019-123]\]. Nevertheless, in real-world clinical practice, not all patients utilised EMS, which may jeopardise myocardial salvage efforts. Moreover, recognising the patient factors affecting STDT or EMS utilisation is more important if the country or province is relatively small, like Korea, which is highly urbanised and densely populated, making it easier to visit the hospital using private transportation. The present study sought to investigate factors associated with pre-hospital delay and utilisation of EMS among STEMI patients.

METHODS
=======

Study design and patient population
-----------------------------------

The study population were derived from the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH). The KAMIR-NIH is a prospective, multi-centre, open, and observational online registry supported by the NIH \[[@b7-kjim-2019-123]\]. A full study flow chart is outlined in [Fig. 1](#f1-kjim-2019-123){ref-type="fig"}. The inclusion criteria for this analysis were as follows: (1) final diagnosis of STEMI; (2) underwent PPCI; and (3) STDT within 12 hours. A total of 4,874 STEMI patients were included in the present study. Patients were categorised into two groups according to STDT, utilising the first quartile of the distribution as a cut-off value ([Table 1](#t1-kjim-2019-123){ref-type="table"} and [Supplementary Fig. 1](#SD2-kjim-2019-123){ref-type="supplementary-material"}): STDT ≤ 60 minutes and STDT \> 60 minutes.

Symptoms were classified as typical if possible ischemic symptoms included various combinations of chest, upper extremity, mandibular, or epigastric discomfort that were sustained \> 20 minutes \[[@b8-kjim-2019-123]\]. Atypical symptoms included abdominal pain, dyspnoea, weakness, syncope, mental change, nausea, vomiting, and a lack of symptoms. STEMI was diagnosed by a new ST elevation in at least two contiguous leads, measuring \> 0.2 mV in leads V1 to 3 or 0.1 mV in all other leads, or a new left bundle branch block on a 12-lead electrocardiogram and an increase in cardiac markers \[[@b8-kjim-2019-123]\]. Cardiogenic shock was confirmed at the time of admission according to clinical criteria: hypotension (systolic blood pressure \< 90 mmHg or catecholamines required to maintain a systolic blood pressure ≥ 90 mmHg), signs of pulmonary congestion, and impaired end-organ perfusion \[[@b9-kjim-2019-123]\]. Among the type of hospital visits, EMS category was only defined as the patients who visited PCI centre by EMS, PCI-centre category defined as the patients who visited the PCI centre by public or their own transportation, and non-PCI centre category was defined as the patients who were transferred from a non-PCI centre to a PCI centre by any mode of transport.

Study variables, outcome measures, and data collection
------------------------------------------------------

Baseline characteristics, including demographics, risk factors, and vital signs, were identified at the time of presentation. All patients received evidence-based drugs after establishment of clinical diagnosis \[[@b10-kjim-2019-123]-[@b12-kjim-2019-123]\]. PPCI was performed according to the American and European guidelines valid at time of enrolment \[[@b10-kjim-2019-123]-[@b12-kjim-2019-123]\], while critical decisions were made at the discretion of the operators. In-hospital mortality and peri-procedural complications were also recorded. All major adverse cardiac events (MACE), including all-cause death, myocardial infarction, or repeat percutaneous coronary intervention (target lesion, target vessel revascularization, or non-target vessel revascularization) were recorded during the 3 years of follow-up. If the patient did not visit the hospital, the outcome data were retrieved from hospital electronic medical records and/or a telephone interview. Attending physicians obtained all clinical data with the assistance of trained clinical research coordinators. The committee of the KAMIR-NIH consisted of healthcare professionals who governed and reviewed all registered data to ensure the adequacy and accuracy of the study. The study protocols were in accordance with the Declaration of Helsinki and were approved by the Institutional Review Board of each participating center (CNUH-2016-075). All patients provided written informed consent.

Statistical analyses
--------------------

Discrete or categorical variables were analysed using chi-square or Fisher's exact tests. Continuous variables were analysed using unpaired t tests or Mann-Whitney rank-sum tests according to their distribution. For comparison of multiple groups, the Mantel-Haenszel statistic or analysis of variance were used to test differences according to their distribution. To identify predictors of delayed STDT or not utilising EMS, univariate and multivariate logistic regression analyses were performed. The multivariate model was constructed using all variables with a significance of *p* \< 0.1 in the univariate analysis, and all relevant variables and their interaction terms could affect pre-hospital delay. A list of candidate variables is presented in [Supplementary Table 1](#SD1-kjim-2019-123){ref-type="supplementary-material"}. The final multivariate model was then constructed using backward elimination to identify the best Akaike's information criterion; odds ratios (ORs) and 95% confidence intervals (CIs) were identified. The 3-year cumulative incidence of events was demonstrated by Kaplan-Meier survival curves followed by log-rank or Breslow tests. The Cox proportional hazard model was used to calculate hazard ratios (HRs) and 95% CIs to compare between-group differences in the cumulative incidence of clinical events. All analyses were two-tailed, and clinical significance was defined as *p* \< 0.05. Statistical analyses were performed using SPSS 25.0 for windows (IBM Co., Armonk, NY, USA) and R version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria).

RESULTS
=======

Baseline clinical characteristics of patients with delayed STDT
---------------------------------------------------------------

The baseline clinical characteristics of the study population are presented in [Table 1](#t1-kjim-2019-123){ref-type="table"}. The total population had a median STDT of 120 minutes (60 to 220), median DTBT of 58 minutes (45 to 71), and median TIT of 178 minutes (120 to 282). The relationship between time intervals in STEMI is shown in [Fig. 2](#f2-kjim-2019-123){ref-type="fig"}. Although DTBT showed a modest correlation with TIT (*r* = 0.172, *p* \< 0.001), the most significant correlation was seen between STDT and TIT (*r* = 0.989, *p* \< 0.001). A total of 1,386 patients (28.4%) visited a hospital within 60 minutes, with a median TIT of 100 minutes (83 to 118), with 77.8% patients experiencing a TIT ≤ 120 minutes. The STDT \> 60 minutes group included a higher proportion of older female patients and those who experienced atypical STEMI symptoms at presentation. The incidence of patients who experienced angina prior to presentation (expressed as "renewed ischemia") was higher in STDT \> 60 minutes group. Only 14.5% of patients with STDT \> 60 minutes utilised EMS and 60.9% initially visited a non-PCI centre, whereas 44% of patients who visited within 60 minutes utilised EMS. Patients with STDT ≤ 60 minutes presented with a higher incidence of cardiogenic shock. The incidence of dyslipidaemia and familial history of ischemic heart disease (IHD) were lower in the STDT \> 60 minutes group, whereas the incidence of diabetes was higher in the STDT \> 60 minutes group. Peri-procedural echocardiograms showed a lower left ventricular ejection fraction in the STDT \> 60 minutes group. Subgroup analysis, which consisted of patients with cardiogenic shock (n = 282), produced results similar to those presented above. However, there were no significant differences in the incidence of diabetes, dyslipidaemia, and a familial history of IHD.

Medical treatments, procedural findings, and in-hospital outcomes
-----------------------------------------------------------------

Detailed data of the medications administered during hospitalisation and the follow-up period are shown in [Table 2](#t2-kjim-2019-123){ref-type="table"}. There was a difference regarding the use of P2Y12 inhibitors between groups; otherwise, no significant differences were observed. As shown in [Table 2](#t2-kjim-2019-123){ref-type="table"}, there were no significant differences in treatment procedures based on STDT status, even among patients with cardiogenic shock. After PPCI, the overall survival rate from STEMI was excellent in the total population (4.2%). The rates of in-hospital mortality and complications did not differ according to the delay in STDT, except for those with ventricular tachyarrhythmia. Among patients with cardiogenic shock, the in-hospital mortality rate was higher in the STDT \> 60 minutes group; however, there was no difference in the rate of complications.

Predictors of pre-hospital delay (STDT \> 60 minutes)
-----------------------------------------------------

[Fig. 3](#f3-kjim-2019-123){ref-type="fig"} shows the results of univariate and multivariate logistic regression analysis to identify predictors of delayed STDT. The performance of these logistic regression models was assessed by c-statistics, revealing moderate to good levels of prediction (0.721 for all patients and 0.776 for patients with cardiogenic shock, respectively).

Old age (OR, 1.30; 95% CI, 1.11 to 1.53; *p* \< 0.001), female gender (OR, 1.27; 95% CI, 1.05 to 1.54; *p* = 0.012), and renewed ischemia (OR, 1.32; 95% CI, 1.12 to 1.57; *p* = 0.001) were identified as independent risk factors of delayed STDT in all STEMI patients. Although it was not statistically significant, atypical symptoms of old age (OR, 1.43; 95% CI, 0.99 to 2.05; *p* = 0.056) seemed to be an independent risk factor of delayed STDT in all STEMI patients.

Cardiogenic shock (OR, 0.67; 95% CI, 0.51 to 0.88; *p* = 0.003) and utilisation of EMS (OR, 0.20; 95% CI, 0.17 to 0.23; *p* \< 0.001) were predictive factors for visiting a hospital within 60 minutes. Among patients with cardiogenic shock, old age (OR, 1.85; 95% CI, 1.04 to 3.29; *p* = 0.036), female (OR, 2.21; 95% CI, 1.14 to 4.28; *p* = 0.019), and diabetes (OR, 1.89; 95% CI, 1.05 to 3.40; *p* = 0.033) were independent predictors of delayed STDT. In contrast, utilisation of EMS was related to STDT within 60 minutes (OR, 0.15; 95% CI, 0.08 to 0.28; *p* \< 0.001).

Clinical outcomes and predictors of non-utilisation of EMS
----------------------------------------------------------

Significant differences in baseline characteristics were observed for certain types of hospital visits ([Table 3](#t3-kjim-2019-123){ref-type="table"}). After the index procedure for treating STEMI, the clinical outcomes according to the type of hospital visit were illustrated in [Fig. 4](#f4-kjim-2019-123){ref-type="fig"}. Among the all study population, the mortality rate of the EMS group was similar to that of the non-PCI centre group ([Fig. 4A](#f4-kjim-2019-123){ref-type="fig"}), although the incidence of cardiogenic shock was higher in the EMS group than in other groups. In a subgroup analysis of patients with cardiogenic shock, utilising EMS was associated with more favourable outcomes, as compared to the non-PCI centre group ([Fig. 4B](#f4-kjim-2019-123){ref-type="fig"}). This trend continued during the 3-year follow-up period, in terms of the cumulative incidence of MACE ([Fig. 4C](#f4-kjim-2019-123){ref-type="fig"} and [4D](#f4-kjim-2019-123){ref-type="fig"}).

To identify risk factors associated with non-utilisation of EMS, several factors were included as candidate variables ([Supplementary Table 1](#SD1-kjim-2019-123){ref-type="supplementary-material"}). [Fig. 5](#f5-kjim-2019-123){ref-type="fig"} shows the results of univariate and multivariate logistic regression analyses to identify predictors of non-utilisation of EMS. The final multivariate logistic regression analysis showed moderate to good levels of prediction (c-statistics, 0.715). Female gender was associated with non-utilisation of EMS (OR, 1.25; 95% CI, 1.03 to 1.51; *p* = 0.022). Cardiogenic shock (OR, 0.34; 95% CI, 0.27 to 0.44; *p* \< 0.001), previous MI (OR, 0.61; 95% CI, 0.47 to 0.80; *p* \< 0.001), familial history of IHD (OR, 0.75; 95% CI, 0.57 to 0.98; *p* = 0.033), and off-hour visits (OR, 0.81; 95% CI, 0.71 to 0.93; *p* = 0.003) were independent predictors of the utilisation of EMS.

DISCUSSION
==========

The present study evaluated factors predicting a pre-hospital delay by evaluating the STDT and utilisation of EMS among STEMI patients who underwent PPCI. The major findings were as follows. First, improved STDT was associated with an overall improvement in TIT. Second, old age, female gender, and renewed ischemia were independent factors for predicting delayed STDT. Third, patients who utilised EMS were more likely to arrive at the hospital within 60 minutes, regardless of the presence of cardiogenic shock. Fourth, female gender was an independent factor predicting non-utilisation of EMS, whereas cardiogenic shock, previous MI, familial history of IHD, and off-hour visits were associated with non-utilisation of EMS.

Minimising TIT is a major determinant of myocardial salvage, as the prolonged duration of ischemia is related to myocardial necrosis, as evidenced by contrast-enhanced magnetic resonance \[[@b13-kjim-2019-123]\]. The median DTBT observed in this study was close to the target of 60 to 90 minutes between symptom onset and arrival at the hospital, suggested by current guidelines \[[@b12-kjim-2019-123],[@b14-kjim-2019-123]\]. However, adherence to these guidelines provided no improvement in pre-hospital delay, and took more time than expected. The median STDT of the total study population was 120 min, consistent with previous studies which showed median STDT ranges of 120 to 171 minutes in the United States, Japan, and Korea \[[@b15-kjim-2019-123]-[@b17-kjim-2019-123]\]. Since TIT was more closely related to STDT than to DTBT, only a few patients (25.5%) achieved the goal of TIT within 120 minutes and 51% within 180 minutes for myocardial salvage, as suggested by previous studies \[[@b18-kjim-2019-123],[@b19-kjim-2019-123]\].

After stratification by STDT with a cut-off of 60 minutes, approximately one-third of all patients were categorised into the STDT ≤ 60 minutes group. The median STDT of this group was 39 minutes (29 to 56), and 77.8% achieved TIT within 120 minutes. In contrast, only 4.7% of patients in the STDT \> 60 minutes group achieved TIT within 120 minutes, with a median STDT of 169 minutes (111 to 273). These time trends were similar among patients with cardiogenic shock. Consequently, to improve TIT in real-world clinical practice, reducing pre-hospital delays may be more important than reducing DTBT. A target STDT of 60 minutes would therefore be reasonable to achieve TIT within 120 to 180 minutes.

STDT consists of two main components: patient decision time and transport time \[[@b20-kjim-2019-123]\]. Previous studies have focused on identifying the clinical, socioeconomic, or regional factors that cause a delayed STDT among STEMI patients \[[@b15-kjim-2019-123],[@b20-kjim-2019-123]-[@b28-kjim-2019-123]\]. Those risk factors were female gender \[[@b20-kjim-2019-123]-[@b25-kjim-2019-123]\], older age \[[@b21-kjim-2019-123]-[@b23-kjim-2019-123],[@b26-kjim-2019-123]\], diabetes \[[@b21-kjim-2019-123]-[@b24-kjim-2019-123]\], and atypical symptoms \[[@b22-kjim-2019-123],[@b25-kjim-2019-123]-[@b27-kjim-2019-123]\]. Other predictors might be night time presentation \[[@b15-kjim-2019-123],[@b23-kjim-2019-123]\], longer decision time \[[@b20-kjim-2019-123],[@b25-kjim-2019-123]\], and non-utilisation EMS \[[@b15-kjim-2019-123],[@b22-kjim-2019-123],[@b28-kjim-2019-123],[@b29-kjim-2019-123]\]. Although public campaigns and educational programs targeting those factors have been implemented, there is little evidence that they have successfully reduced treatment delays \[[@b30-kjim-2019-123]\]. The data presented here suggest that recent efforts in Korea have not been effective for reducing STDT and TIT. This phenomenon may be the result of a wider range target for STDT of 2 to 3 hours, compared to the much shorter duration shown here. Moreover, it is doubtful that STDT could be reduced by educational programs aimed at the general public.

Based on studies using preventive interventions, which revealed that high-risk prevention strategies could increase the efficiency of public medical education \[[@b31-kjim-2019-123],[@b32-kjim-2019-123]\], we sought to identify crucial factors related to a delay STDT \> 60 minutes among STEMI patients. We confirmed that old age, female gender, and renewed ischemia were independent factors predictive of delayed STDT. Both older age and female gender have previously been associated with atypical symptoms, and have been shown to strongly affect STDT \[[@b25-kjim-2019-123],[@b26-kjim-2019-123]\]; hence, we included the interaction terms in the multivariate analyses. Because patients who presented with cardiogenic shock were likely to visit the hospital earlier, an additional subgroup analysis for cardiogenic shock was performed. Among patients presenting with cardiogenic shock, old age, female gender, and diabetes were identified as independent risk factors associated with STDT \> 60 minutes.

Although the socioeconomic status of aged and female patients would have affected STDT in a similar way to that found in previous studies examining decision time, the current results suggest that other distinguishing factors may need to be addressed. Before the index presentation of STEMI, some patients (20.8%) had already experienced ischemic symptoms. These experiences may have influenced STDT because STEMI symptoms could be misinterpreted as "simple" symptoms. The renewed ischemia may interfere with the decision-making process and result in a failure to achieve the "golden hour" for myocardial salvage. Furthermore, the association between old age and atypical symptoms was significantly related to delay of STDT, suggesting that we should focus on those who present with both variables simultaneously. Thus, it is necessary to modify public education programs to ensure that patients with suspected angina and/or older patients with atypical symptoms visit their healthcare providers.

Jager et al. \[[@b24-kjim-2019-123]\] reported that one of the strongest predictors of shorter STDT is cardiogenic shock. Patients with cardiogenic shock usually present earlier because the warning signs of tissue hypoperfusion and decompensated heart failure, such as impaired consciousness, hypotension, and desaturation, encourage patients to visit the hospital. Moreover, delay of reperfusion is a strong predictor of adverse outcomes among patients with cardiogenic shock. Any factors delaying prompt treatment should therefore be identified and removed \[[@b33-kjim-2019-123]\]. Our study confirmed that cardiogenic shock was related to timely arrival at the hospital. Among patients with cardiogenic shock, old age, female gender, and diabetes remained independent predictors for delayed STDT \> 60 minutes.

Kim et al. \[[@b20-kjim-2019-123]\] reported that the median decision time to seek medical assistance is 20 to 25 minutes in Korea. Based on this finding, transport time, which accounts for the remainder of STDT, might be calculated indirectly as \> 60 minutes. If patients initially utilise EMS to avoid traffic congestion in overcrowded urban areas, the transport time and STDT may be reduced. Linear regression curves classified by types of hospital visits ([Supplementary Fig. 2](#SD3-kjim-2019-123){ref-type="supplementary-material"}) found that utilisation of EMS was related to shorter STDT; conversely, direct visits to PCI centres or transfer from non-PCI centres were related to longer STDT. However, the data presented here showed that direct visits to PCI centres (28%) or transfers from non-PCI centres (50.3%) were more frequent, and utilisation of EMS (21.7%) was less frequent than that seen in previous studies conducted in Western countries \[[@b29-kjim-2019-123],[@b34-kjim-2019-123],[@b35-kjim-2019-123]\]. Despite frequencies similar to those of other Asian countries \[[@b36-kjim-2019-123],[@b37-kjim-2019-123]\], a significant need to identify predictors of non-utilisation of EMS among STEMI patients remains. Although certain clinical variables have been linked to non-use of EMS services, these results remain controversial \[[@b36-kjim-2019-123]-[@b39-kjim-2019-123]\]. In accordance with other studies, old age was not shown to be an independent factor for non-utilisation of EMS. In contrast, female gender was associated with non-utilisation of EMS, whereas cardiogenic shock, previous MI, familial history of IHD, and off-hour visits were all related to use of EMS.

Study limitations
-----------------

The current study has several limitations that should be considered. First, it was a retrospective analysis of an observational cohort, which has some potential for selection and confounding bias. It is difficult to evaluate the clinical impact of STDT or EMS using a randomised prospective clinical trial due to methodological and ethical problems. This study may, therefore, represent one of the largest studies to date for identifying predictors in real-world practice. Second, we could not fully explain the mechanisms by which the predictors identified in this analysis influence STDT or EMS. Socioeconomic status, education level, and familial environment may all be related to a delay in STDT; however, we were not able to evaluate those effects in this analysis. The impact of those variables on STDT has been established in previous studies; thus, the limitation of the current study is somewhat reduced. In addition, there were no data on geographical characteristics, which may be associated with STDT or the accessibility of EMS. Although this study sought to identify patient factors for reducing STDT using a high-risk prevention strategy, educational programs should also pay close attention to demographic characteristics. Third, our data will require continuous updating to reflect recent temporal trends. We expect to overcome these limitations by continuing our analysis of the KAMIR-NIH data, with new results from the 5-year follow-up study helping to overcome these limitations.

In conclusion, pre-hospital delay, as defined by STDT, may be an important target for reducing TIT. To improve TIT to a maximum of 120 to 180 minutes, we suggest that STDT be reduced to \< 60 minutes. Several clinical risk factors including old age, female gender, and renewed ischemia were all identified as independent risk factors for delayed STDT. Utilisation of EMS was the only modifiable predictor related to improvements in pre-hospital delay. In contrast, female gender was identified as an independent factor associated with non-utilisation of EMS, whereas cardiogenic shock, previous MI, familial history of IHD, and off-hour visits were all independent factors related to the promotion of EMS. Identification of risk factors associated with delayed STDT or non-utilisation of EMS among STEMI patients is necessary, therefore, to establish high-risk prevention strategies to reduce TIT in real-world practice. Healthcare providers should consider intensive educational programs focusing on improving STDT or encouraging use of EMS to reduce TIT.

KEY MESSAGE
===========

1\. Pre-hospital delay, as defined by symptom-todoor time (STDT), is an important target for reducing total ischemic time (TIT).

2\. Old age, female gender, and renewed ischemia were independent factors for predicting delayed STDT.

3\. Utilisation of emergency medical services (EMS) was the only modifiable predictor for reducing STDT. Therefore, educational programs focusing on the use of EMS should be considered to reduce TIT.
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Candidate variables for model construction

###### 

Histograms and distribution curves according to timer intervals. (A) Distribution of symptom-to-door time. (B) Distribution of door-to-balloon time. (C) Distribution total ischemic time.

###### 

Trends of symptom-to-door time (STDT) according to age and type of hospital visits. PCI, percutaneous coronary interventionfi; EMS, emergency medical services.

![Study f low chart. STEMI, ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STDT, symptom-to-door time; DTBT, door-to-balloon time; EMS, emergency medical services.](kjim-2019-123f1){#f1-kjim-2019-123}

![Scatter plots according to time interval. The relationships among time intervals in ST-segment elevation myocardial infarction are shown as scatter plots and linear regression lines: (A) between symptom-to-door time (STDT) and total ischemic time (TIT), (B) door-to-balloon time (DTBT) and TIT, and (C) STDT and DTBT. The STDT and TIT showed a significant correlation (*r* = 0.989, *p* \< 0.001).](kjim-2019-123f2){#f2-kjim-2019-123}

![Predictors for pre-hospital delay (symptom-to-door time \[STDT\] \> 60 minutes). The results of uni- and multivariate analyses in (A) all patients and (B) patients with cardiogenic shock were outlined. Only utilising emergency medical services (EMS) was an independent predictor of shortening pre-hospital delay, regardless of haemodynamics. OR, odds ratio; CI, confidence interval; MI, myocardial infarction. a Multivariate analysis was performed using backward elimination with variables that showed a *p* \< 0.1 in univariate analysis.](kjim-2019-123f3){#f3-kjim-2019-123}

![Clinical outcomes according to type of hospital visit (emergency medical services \[EMS\] vs. non-percutaneous coronary intervention \[PCI\] centre vs. PCI centre). Survival analyses using Kaplan-Meier curves with cumulative hazards of (A) allcause death of all patients and (B) patients with cardiogenic shock within 30 days; and (C) major adverse cardiac events of all patients and (D) patients with cardiogenic shock at 3 years. HR, hazard ratio; CI, confidence interval; NA, not available.](kjim-2019-123f4){#f4-kjim-2019-123}

![Predictors for non-utilisation of emergency medical services (EMS). Univariate and multivariate analyses revealed predictors for non-utilisation of EMS. OR, odds ratio; CI, confidence interval; MI, myocardial infarction. ^a^Multivariate analysis was performed using backward elimination with variables that showed a *p* \< 0.1 in univariate analysis.](kjim-2019-123f5){#f5-kjim-2019-123}

###### 

Baseline clinical characteristics

  Characteristic                                                   Total (n = 4,874)                  All patients (n = 4,874)         Cardiogenic shock (n = 282)                                                                                      
  ---------------------------------------------------------------- ---------------------------------- -------------------------------- ---------------------------------- ---------- ------------------------------- ---------------------------------- ----------
  Age, yr                                                          62.1 ± 12.6                        59.9 ± 12.3                      63.0 ± 12.7                        \< 0.001   63.0 ± 12.5                     68.3 ± 13.0                        0.001
  Age \> 65 yr                                                     1,983 (40.7)                       458 (33.0)                       1,525 (43.7)                       \< 0.001   55 (42.3)                       94 (61.8)                          0.002
  Male sex                                                         3,900 (80.0)                       1,184 (85.4)                     2,716 (77.9)                       \< 0.001   107 (82.3)                      103 (67.8)                         0.008
  Holiday visits                                                   1,542 (31.6)                       449 (32.4)                       1,093 (31.3)                       0.494      47 (36.2)                       48 (31.6)                          0.494
  Off-hour visits^[a](#tfn1-kjim-2019-123){ref-type="table-fn"}^   1,951 (40.0)                       597 (43.1)                       1,354 (38.8)                       0.007      57 (43.8)                       69 (45.4)                          0.888
  Atypical symptoms                                                888 (18.2)                         236 (17.0)                       652 (18.7)                         0.008      23 (17.7)                       38 (25.0)                          0.180
  Renewed ischemia                                                 1,012 (20.8)                       242 (17.5)                       720 (22.1)                         \< 0.001   13 (10.0)                       26 (17.1)                          0.121
  Utilised EMS                                                     1,060 (21.7)                       555 (44.0)                       505 (14.5)                         \< 0.001   79 (60.8)                       41 (27.0)                          \< 0.001
  Non-PCI centre                                                   2,451 (50.3)                       327 (23.6)                       2,124 (60.9)                       \< 0.001   20 (15.4)                       82 (53.9)                          \< 0.001
  STDT, min                                                        164.4 ± 146.8 (120 \[60--220\])    39.3 ± 16.4 (39 \[29--56\])      214.1 ± 146.0 (169 \[111--273\])   \< 0.001   36.1 ± 16.8 (35 \[24--52\])     205.5 ± 146.5 (151 \[105--247\])   \< 0.001
  DTBT, min                                                        60.8 ± 22.9 (58 \[45--71\])        62.9 ± 24.3 (60 \[46--74\])      59.9 ± 22.2 (57 \[45--70\])        \< 0.001   64.9 ± 27.3 (61 \[47--78\])     64.3 ± 28.0 (59 \[46--76\])        0.865
   ≤ 60                                                            2,755 (56.5)                       719 (51.9)                       2,036 (58.4)                       \< 0.001   63 (48.5)                       83 (54.6)                          0.363
   ≤ 90                                                            4,573 (93.8)                       1,279 (92.3)                     3,294 (94.4)                       0.006      117 (90.0)                      135 (88.8)                         0.898
  TIT, min                                                         225.1 ± 149.1 (178 \[120--282\])   102.2 ± 29.3 (100 \[83--118\])   274.0 ± 149.5 (224 \[167--335\])   \< 0.001   101.0 ± 32.4 (95 \[80--117\])   269.8 ± 152.7 (218 \[165--313\])   \< 0.001
   ≤ 120                                                           1,242 (25.5)                       1,078 (77.8)                     164 (4.7)                          \< 0.001   100 (76.9)                      10 (6.6)                           \< 0.001
   ≤ 180                                                           2,487 (51.0)                       1,358 (98.0)                     1,129 (32.4)                       \< 0.001   125 (96.2)                      51 (33.6)                          \< 0.001
  SBP, mmHg                                                        125.1 ± 32.7                       121.3 ± 36.6                     126.6 ± 30.9                       \< 0.001   55.0 ± 34.5                     60.1 ± 30.6                        0.197
  Heart rate, /min                                                 75.7 ± 20.5                        73.9 ± 22.9                      76.5 ± 19.4                        \< 0.001   57.9 ± 37.0                     66.3 ± 34.7                        0.051
  GRACE score                                                      123 (\[98--149\])                  118 (\[94--146\])                124 (\[100--151\])                 \< 0.001   157 (\[139--177\])              163 (\[144--190\])                 0.020
  Cardiogenic shock                                                282 (5.8)                          130 (9.4)                        152 (4.4)                          \< 0.001   \-                              \-                                 \-
  Hypertension                                                     2,229 (45.7)                       637 (46.0)                       1,592 (45.6)                       0.866      68 (52.3)                       72 (47.4)                          0.479
  Diabetes                                                         1,160 (23.8)                       300 (21.6)                       860 (24.7)                         0.029      35 (26.9)                       55 (36.2)                          0.125
  Dyslipidaemia                                                    523 (10.7)                         169 (12.2)                       354 (10.1)                         0.042      12 (9.2)                        13 (8.6)                           1.000
  Smoking                                                          2,223 (45.6)                       659 (47.5)                       1,564 (44.8)                       0.093      57 (43.8)                       53 (34.9)                          0.156
  Familial history                                                 309 (6.3)                          108 (7.8)                        201 (5.8)                          0.011      7 (5.4)                         4 (2.6)                            0.378
  Previous MI                                                      283 (5.8)                          97 (7.0)                         186 (5.3)                          0.140      11 (8.5)                        10 (6.6)                           0.709
  History of stroke                                                220 (4.5)                          53 (3.8)                         167 (4.8)                          0.166      5 (3.8)                         7 (4.6)                            0.985
  LVEF, %                                                          50.7 ± 10.2                        52.4 ± 9.9                       50.0 ± 10.2                        \< 0.001   50.0 ± 11.9                     43.7 ± 11.9                        \< 0.001
  CK-MB, ng/mL                                                     174.0 ± 185.4                      157.0 ± 162.0                    180.7 ± 193.6                      \< 0.001   215.2 ± 250.9                   232.1 ± 311.5                      0.615
  Troponin-I, ng/mL                                                77.7 ± 127.0                       69.6 ± 152.3                     80.9 ± 115.4                       0.023      82.9 ± 166.8                    109.5 ± 148.6                      0.207
  Creatinine, g/dL                                                 1.0 ± 0.7                          1.1 ± 0.8                        1.0 ± 0.7                          0.049      1.2 ± 0.4                       1.3 ± 0.6                          0.008

Values are presented as mean ± SD, number (%), or median (interquartile range).

STDT, symptom-to-door time; EMS, emergency medical service; PCI, percutaneous coronary intervention; DTBT, door-toballoon time; TIT, total ischemic time; SBP, systolic blood pressure; GRACE, Global Registry of Acute Coronary Events; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CK-MB, creatine kinase-myocardial band.

Patients who visited hospitals from 6:00 PM to 8:00 AM.

###### 

Medical treatments, procedural findings, and in-hospital outcomes

  Characteristic                                                              Total (n = 4,874)   All population (n = 4,874)   Cardiogenic shock (n = 282)                                     
  --------------------------------------------------------------------------- ------------------- ---------------------------- ----------------------------- ------- ------------ ------------ -------
  Aspirin                                                                     4,861 (99.7)        1,379 (99.5)                 3,482 (99.8)                  0.084   124 (95.4)   149 (98.0)   0.358
  Clopidogrel                                                                 3,074 (63.1)        834 (60.2)                   2,240 (64.2)                  0.009   70 (53.8)    85 (55.9)    0.819
  Ticagrelor                                                                  1,043 (21.4)        325 (23.4)                   718 (20.6)                    0.031   25 (19.2)    25 (16.4)    0.650
  Prasugrel                                                                   607 (12.5)          182 (13.1)                   425 (12.2)                    0.393   15 (11.5)    10 (6.6)     0.211
  Beta-blockers                                                               4,155 (85.2)        1,197 (86.4)                 2,958 (84.8)                  0.180   82 (63.1)    73 (48.0)    0.016
  ACE inhibitors                                                              2,571 (52.7)        733 (52.9)                   1,838 (52.7)                  0.929   52 (40.0)    45 (29.6)    0.088
  ARBs                                                                        1,305 (26.8)        348 (25.1)                   957 (27.4)                    0.105   23 (17.7)    26 (17.1)    1.000
  Statins                                                                     4,464 (91.6)        1,272 (91.8)                 3,192 (91.5)                  0.811   86 (66.2)    89 (58.6)    0.235
  GP IIb/IIIa inhibitor                                                       1,076 (22.1)        309 (22.3)                   767 (22.0)                    0.847   42 (32.3)    44 (28.9)    0.630
  Multi-vessel diseasedz.                                                     2,265 (46.5)        638 (46.0)                   1,627 (46.6)                  0.722   76 (58.5)    95 (62.5)    0.569
  LAD related diseasedz.                                                      2,456 (50.4)        713 (51.4)                   1,743 (50.0)                  0.371   40 (30.8)    55 (36.2)    0.405
  Lesion type B1/B2                                                           2,224 (45.6)        612 (44.2)                   1,612 (46.2)                  0.204   58 (44.6)    62 (40.8)    0.598
  Lesion type C                                                               2,609 (53.5)        754 (54.4)                   1,855 (53.2)                  0.461   69 (53.1)    89 (58.6)    0.422
  Thrombus aspiration                                                         1,854 (38.0)        515 (37.2)                   1,339 (38.4)                  0.444   41 (31.5)    56 (36.8)    0.419
  Using BMS                                                                   131 (2.7)           38 (2.7)                     93 (2.7)                      0.961   9 (6.9)      11 (7.2)     1.000
  IABP                                                                        242 (5.0)           71 (5.1)                     171 (4.9)                     0.806   27 (20.8)    47 (30.9)    0.073
  ECMO                                                                        75 (1.5)            27 (1.9)                     48 (1.4)                      0.182   18 (13.8)    19 (12.5)    0.875
  Complete revascularisation^[a](#tfn2-kjim-2019-123){ref-type="table-fn"}^   4,809 (98.7)        1,369 (98.8)                 3,440 (98.6)                  0.568   123 (94.6)   144 (94.7)   0.748
  Hospital death                                                              207 (4.2)           58 (4.2)                     149 (4.3)                     0.954   33 (25.4)    60 (39.5)    0.017
   Cardiac death                                                              187 (3.8)           54 (3.9)                     133 (3.8)                     0.957   32 (24.6)    55 (36.2)    0.049
   Non-cardiac death                                                          20 (0.4)            4 (0.3)                      16 (0.5)                      0.555   1 (0.8)      5 (3.3)      0.295
  Newly developed HF                                                          172 (3.5)           47 (3.4)                     125 (3.6)                     0.808   9 (6.9)      21 (13.8)    0.093
  VT/VF                                                                       395 (8.1)           134 (9.7)                    261 (7.5)                     0.014   41 (31.5)    54 (35.5)    0.562
  TIMI major bleeding                                                         100 (2.1)           30 (2.2)                     70 (2.0)                      0.812   15 (11.5)    14 (9.2)     0.656
  TIMI minor bleeding                                                         150 (3.1)           38 (2.7)                     112 (3.2)                     0.445   9 (6.9)      10 (6.6)     1.000

Values are presented as number (%).

STDT, symptom-to-door time; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; GP, glycoprotein; dz, disease; LAD, left anterior descending artery; BMS, bare metal stent; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; HF, heart failure; VT/VF, ventricular tachycardia/ventricular fibrillation; TIMI, thrombolysis in myocardial infarction.

Angiographic complete revascularisation was defined as minimum stenosis diameter reduction to less than 20%.

###### 

Comparison of time intervals according to types of hospital visits

  Characteristic      Total population (n = 4,874)      Cardiogenic shock (n = 282)                                                                                                                                                             
  ------------------- --------------------------------- ---------------------------------- ---------------------------------- ---------- --------------------------------- ---------------------------------- --------------------------------- ----------
  Number              1,060 (21.7)                      2,451 (50.3)                       1,363 (28.0)                                  120 (42.5)                        102 (36.2)                         60 (21.3)                         
  Age, yr             61.8 ± 12.7                       62.9 ± 13.1                        61.0 ± 11.8                        \< 0.001   65.1 ± 13.1                       67.9 ± 13.3                        63.9 ± 12.2                       0.113
  Age \> 65 yr        420 (39.6)                        1,074 (43.8)                       489 (35.9)                         \< 0.001   60 (50.0)                         63 (61.8)                          26 (43.3)                         0.054
  Male gender         877 (82.7)                        1,883 (76.8)                       1,140 (83.6)                       \< 0.001   90 (75.0)                         73 (71.6)                          47 (78.3)                         0.625
  Holiday visits      357 (33.7)                        747 (30.5)                         438 (32.1)                         0.155      49 (40.8)                         29 (28.4)                          17 (28.3)                         0.092
  Off-hour visits     471 (44.4)                        911 (37.2)                         569 (41.7)                         \< 0.001   58 (48.3)                         41 (40.2)                          27 (45.0)                         0.477
  Atypical symptoms   220 (20.8)                        401 (16.4)                         267 (19.6)                         0.003      23 (19.2)                         23 (22.5)                          15 (25.0)                         0.643
  Renewed ischemia    195 (18.4)                        512 (20.9)                         305 (22.4)                         0.055      12 (10.0)                         18 (17.6)                          9 (15.0)                          0.247
  STDT, min           94.3 ± 97.8 (60 \[34--118\])      203.2 ± 149.3 (161 \[97--268\])    149.0 ± 151.0 (90 \[48--196\])     \< 0.001   80.3 ± 98.2 (47 \[30--92\])       195.5 ± 159.1 (140 \[85--249\])    105.8 ± 117.7 (60 \[29--119\])    \< 0.001
  DTBT, min           64.3 ± 25.9 (60 \[48--75\])       57.5 ± 21.3 (55 \[43--67\])        63.9 ± 22.4 (61 \[49--75\])        \< 0.001   67.4 ± 28.1 (63 \[50--81\])       63.4 ± 27.6 (58 \[46--76\])        60.9 ± 26.8 (58 \[44--69\])       0.285
   ≤ 60               540 (50.9)                        1,549 (63.2)                       666 (48.9)                         \< 0.001   55 (45.8)                         56 (54.9)                          35 (58.3)                         0.209
   ≤ 90               963 (90.8)                        2,339 (95.4)                       1,271 (93.3)                       \< 0.001   104 (86.7)                        93 (91.2)                          55 (91.7)                         0.448
  TIT, min            158.6 ± 100.5 (130 \[98--183\])   260.7 ± 153.4 (216 \[150--327\])   212.9 ± 153.3 (158 \[109--263\])   \< 0.001   147.8 ± 102.6 (118 \[90--170\])   258.9 ± 166.7 (200 \[141--320\])   166.7 ± 121.1 (110 \[87--217\])   \< 0.001
   ≤ 120              474 (44.7)                        328 (13.4)                         440 (32.3)                         \< 0.001   64 (53.3)                         14 (13.7)                          32 (53.3)                         \< 0.001
   ≤ 180              785 (74.1)                        920 (37.5)                         782 (57.4)                         \< 0.001   95 (79.2)                         41 (40.2)                          40 (66.7)                         \< 0.001
  SBP, mmHg           120.7 ± 35.9                      123.8 ± 31.1                       130.9 ± 32.3                       \< 0.001   57.8 ± 32.5                       56.8 ± 33.6                        59.4 ± 31.5                       0.885
  Heart rate, /min    73.2 ± 23.7                       76.8 ± 19.9                        75.8 ± 18.5                        \< 0.001   60.2 ± 35.7                       68.0 ± 38.0                        57.6 ± 32.2                       0.138
  GRACE score         124 (100--151)                    125 (100--151)                     118 (94--142)                      \< 0.001   160 (139--184)                    172 (149--189)                     152 (138--174)                    0.034
  Cardiogenic shock   120 (11.3)                        102 (4.2)                          60 (4.4)                           \< 0.001                                                                                                          
  Hypertension        511 (48.2)                        1,096 (44.7)                       622 (45.6)                         0.162      64 (53.3)                         47 (46.1)                          29 (48.3)                         0.545
  Diabetes            247 (23.3)                        616 (25.1)                         297 (21.8)                         0.061      35 (29.2)                         32 (31.4)                          23 (38.3)                         0.456
  Dyslipidaemia       124 (11.7)                        204 (8.3)                          195 (14.3)                         \< 0.001   11 (9.2)                          6 (5.9)                            8 (13.3)                          0.270
  Smoking             464 (43.8)                        1,138 (46.4)                       621 (45.6)                         0.349      51 (42.5)                         35 (34.3)                          24 (40.0)                         0.453
  Familial history    82 (7.7)                          127 (5.2)                          100 (7.3)                          0.004      6 (5.0)                           3 (2.9)                            2 (3.3)                           0.709
  Previous MI         87 (8.2)                          87 (3.5)                           109 (8.0)                          \< 0.001   13 (10.8)                         1 (1.0)                            7 (11.7)                          0.008
  Stroke              52 (4.9)                          108 (4.4)                          60 (4.4)                           0.786      5 (4.2)                           5 (4.9)                            2 (3.3)                           0.890

Values are presented as number (%), mean ± SD, or median (interquartile range).

EMS, emergency medical service; PCI, percutaneous coronary intervention; ANOVA, analysis of variance; STDT, symptom-to-door time; DTBT, door-to-balloon time; TIT, total ischemic time; SBP, systolic blood pressure; GRACE, Global Registry of Acute Coronary Events; MI, myocardial infarction.
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